Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,958 public trials 634 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

NCT00118040

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +12 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • South Orange County Surgical Medical Group Inc Laguna Hills, California, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • AccuMed Research Associates Garden City, New York, United States
View Trial Details
Completed

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

NCT00414765

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations
  • USC/Kenneth Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details
Completed

A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

NCT02118337

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Overland Park, Kansas, United States
  • Research Site Louisville, Kentucky, United States
View all 27 locations
View Trial Details

Related conditions